| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2022047145-A1 | Rapidly accelerating fibrosarcoma protein degrading compounds and associated methods of use | 2020-08-28 |
| WO-2022040799-A1 | Antimicrobial composition | 2020-08-27 |
| WO-2021127743-A1 | Substituted hydroxystilbene compounds and derivatives synthesis and uses thereof | 2019-12-23 |
| WO-2021086833-A1 | Small molecule inhibitors of kras g12c mutant | 2019-10-28 |
| TW-202130645-A | Small molecule inhibitors of kras g12c mutant | 2019-10-28 |
| WO-2019204537-A1 | N-[4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol e-2-carboxamide derivatives and related compounds as rip1 kinase inhibitors for treating e.g. irritable bowel syndrome (ibs) | 2018-04-20 |
| CN-112074519-A | N- [ 4-oxo-2, 3-dihydro-1, 5-benzoxazepin-3-yl ] -5, 6-dihydro-4H-pyrrolo [1,2-B ] pyrazole-2-carboxamide derivatives and related compounds as RIP1 kinase inhibitors for the treatment of e.g. Irritable Bowel Syndrome (IBS) | 2018-04-20 |
| EP-3781571-A1 | N-[4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol e-2-carboxamide derivatives and related compounds as rip1 kinase inhibitors for treating e.g. irritable bowel syndrome (ibs) | 2018-04-20 |
| US-2021032271-A1 | Pyridine lactam compounds and methods of use thereof | 2018-04-20 |
| JP-2021522206-A | N- [4-oxo-2,3-dihydro-1,5-benzoxazepine-3-yl] -5,6-dihydro-4H-pyrrolo [1,2-b] pyrazole-2-carboxamide derivative and Related compounds as RIP1 kinase inhibitors for the treatment of irritable bowel syndrome (IBS), for example | 2018-04-20 |
